Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 26, 2023

Details for Patent: 7,975,690

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which drugs does patent 7,975,690 protect, and when does it expire?

Patent 7,975,690 protects ONZETRA XSAIL and XHANCE and is included in two NDAs.

This patent has one hundred and fifty-seven patent family members in twenty-six countries.

Summary for Patent: 7,975,690

Title:	Nasal devices
Abstract:	The present invention relates to a nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.
Inventor(s):	Djupesland; Per Gisle (Olso, NO)
Assignee:	OptiNose AS (Oslo, NO)
Application Number:	10/480,582
Patent Claim Types: see list of patent claims	Use; Delivery; Device; Formulation;

Drugs Protected by US Patent 7,975,690

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Currax	ONZETRA XSAIL	sumatriptan succinate	POWDER;NASAL	206099-001	Jan 27, 2016		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing	Y			METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY	See Plans and Pricing
Optinose Us Inc	XHANCE	fluticasone propionate	SPRAY, METERED;NASAL	209022-001	Sep 18, 2017		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing				METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,975,690

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0114272.8	Jun 12, 2001

PCT Information
PCT Filed	June 12, 2002	PCT Application Number:	PCT/IB02/03034
PCT Publication Date:	January 03, 2003	PCT Publication Number:	WO03/000310

International Family Members for US Patent 7,975,690

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	285810	See Plans and Pricing
Austria	422923	See Plans and Pricing
Austria	427130	See Plans and Pricing
Austria	487506	See Plans and Pricing
Austria	506983	See Plans and Pricing
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Merck

McKinsey

Boehringer Ingelheim

Harvard Business School

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.